Elanco Animal Health (ELAN) Long-Term Debt Issuances (2018 - 2025)

Elanco Animal Health's (ELAN) quarterly Long-Term Debt Issuances came in at $2.1 billion in Q4 2025, up 321.2% quarter-over-quarter from $500.0 million in Q3 2021.

Elanco Animal Health (ELAN) Long-Term Debt Issuances (2018 - 2025) Analysis & Trends

Elanco Animal Health has disclosed Long-Term Debt Issuances across 4 years of filings, most recently posting $2.1 billion for Q4 2025.

  • Long-Term Debt Issuances for Q4 2025 came in at $2.1 billion, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $2.1 billion (changed N/A YoY), and the FY2025 annual result was $2.1 billion, up 501.71% from the prior year.
  • Long-Term Debt Issuances came in at $2.1 billion for Q4 2025 at Elanco Animal Health, up from $500.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $2.1 billion in Q4 2025 to a low of $500.0 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 1.51 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.11 Bn
Dec 31, 2025 2.11 Bn
Sep 30, 2021 500.00 Mn
Sep 30, 2021 500.00 Mn
Dec 31, 2020 250.00 Mn
Dec 31, 2020 250.00 Mn
Sep 30, 2020 4.48 Bn
Sep 30, 2020 4.48 Bn
Mar 31, 2020 79.00 Mn
Mar 31, 2020 79.00 Mn
Dec 31, 2018 22.30 Mn
Dec 31, 2018 22.30 Mn